Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, September 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 62 articles: HTML format

Single Articles

1. XU Y, Wu W, Zhang Z, Dong Y, et al
   Si-Si-Gu-Ben granules alleviate diarrhea-predominant irritable bowel syndrome by modulating gut microbiota and suppressing the TLR4/NF-kappaB pathway: A combined clinical and animal study.
   J Ethnopharmacol. 2026 Sep 4:122352. doi: 10.1016/j.jep.2026.122352.
   PubMed    
   Abstract available
   
   

2. KHALIL C, Suchak KK, Amaro IF, Krut Z, et al
   Patients' Real-World Experiences With Pharmacologic Therapies for Irritable Bowel Syndrome With Constipation: A Mixed-Methods Analysis and Classification of Social Media and E-Forum Posts.
   Neurogastroenterol Motil. 2026;38:e70432.
   PubMed    
   Abstract available
   
   

3. GROEN SR, Vork L, Weerts ZZRM, Mujagic Z, et al
   Phenotyping Increased Urge to Defecate in Irritable Bowel Syndrome: Analysis of Symptom, Sensory, and Psychological Profiles.
   United European Gastroenterol J. 2026;14:e70287.
   PubMed    
   Abstract available
   
   

4. LIU N, Huang Y, Wang Y, Qiao H, et al
   Pathogenesis and therapeutic strategies for irritable bowel syndrome: an integrated perspective from dynamic balance theory of Chinese medicine.
   Front Med (Lausanne). 2026;13:1823683.
   PubMed    
   Abstract available
   
   

5. AN L, Luan M, Yang Y, Wang S, et al
   The algorithmic epistemic inversion in gastroenterology: how social media and psychological vulnerability fuel secondary risks in IBD and IBS management.
   Front Public Health. 2026;14:1871219.
   PubMed    
   Abstract available
   
   

6. DICHTER J
   Bile Acid Metabolism as a Unifying Readout for Diet, Microbiome Function, and Gastrointestinal Disease.
   FASEB J. 2026;40:e72273.
   PubMed    
   Abstract available
   
   

7. ZHANG Z, Holton M, Ferrer DM, Tripp AD, et al
   Metagenome-scale modeling to assess microbiome metabolic complementarity for precision microbiota transplantation therapies.
   Gut Microbes. 2026;18:2725403.
   PubMed    
   Abstract available
   
   

8. JIA Z, Gu X
   Initiating multi-strain probiotics is associated with clinically meaningful symptom relief, better quality of life, and fewer treatment escalations in IBS-D/IBS-M: a Chinese real-world propensity-matched cohort study.
   Front Med (Lausanne). 2026;13:1900112.
   PubMed    
   Abstract available
   
   

9. SUN X, Lin Q, Xu Y, Hu P, et al
   Ameliorating Effects and Autonomic Mechanisms of Transcutaneous Auricular Vagus Nerve Stimulation on Abdominal Pain in Patients With Functional Dyspepsia and Irritable Bowel Syndrome.
   Neurogastroenterol Motil. 2026;38:e70224.
   PubMed    
   Abstract available
   
   

10. JO D, Farahmand Y, Friedman K, Shepherd JM, et al
    Relationships Between Risky Substance Use and Irritable Bowel Syndrome (IBS) Severity, Mental Health, and Smoking-Related Processes in Adults with IBS Who Smoke.
    J Dual Diagn. 2026 Sep 1:1-13. doi: 10.1080/15504263.2026.2726789.
    PubMed    
    Abstract available
    
    

11. KIM M, Vuong HE
    Indole-AhR signaling shapes emotional regulation.
    Cell Rep. 2026;45:117747.
    PubMed    
    Abstract available
    
    

12. QIU YN, Zhong BH, Zhang HH, Dai SX, et al
    Dynamic precision therapy in chronic gastrointestinal diseases: A focus on gastroesophageal reflux disease and inflammatory bowel disease-A narrative review and conceptual perspective.
    Ther Adv Gastroenterol. 2026;19:17562848261483778.
    PubMed    
    Abstract available
    
    

13. YANG F, Tian D, Zhang Y, Xia Z, et al
    Traditional Chinese medicine formulation Chang-Kang-Fang restores gut-brain homeostasis in IBS-D via the Lactobacillus johnsonii-indole-3-lactic acid-aryl hydrocarbon receptor/interleukin-22 axis.
    Phytomedicine. 2026;161:158786.
    PubMed    
    Abstract available
    
    

14. WANG Y, Li P, Dong Y, Zhang X, et al
    Neuroimmune regulation of visceral pain: roles of microglia, purinergic signaling, and neuroinflammation.
    Front Immunol. 2026;17:1934162.
    PubMed    
    Abstract available
    
    

15. BLAKE S, Cannon H, Shantikumar S
    The Association Between Attention-Deficit Hyperactivity Disorder and Gastrointestinal Symptoms: A Systematic Review and Meta-Analysis.
    J Atten Disord. 2026 Sep 10:10870547261469626. doi: 10.1177/10870547261469626.
    PubMed    
    Abstract available
    
    

16. TAO W, Yu Y, Huang X, Huang J, et al
    Global research trends in enteric nervous system and gut microbiota: a bibliometric analysis (2005-2025).
    Front Cell Infect Microbiol. 2026;16:1806356.
    PubMed    
    Abstract available
    
    

17. ABDELSHAFI A, Abdelhamid ZG, Osama B, Mohammed YA, et al
    Severity of irritable bowel syndrome and its correlates among Middle East and North African medical students: a multicentric cross sectional study.
    Sci Rep. 2026;16:28211.
    PubMed    
    Abstract available
    
    

18. LACY BE, Petrov JC, Castillo PR
    Sleep and Disorders of Gut-Brain Interaction.
    Gastroenterol Hepatol (N Y). 2026;22:362-370.
    PubMed    
    Abstract available
    
    

19. PEREYRA F, Schlottmann F, Salvatori C, Smolarczuk A, et al
    Effectiveness of a FODMAP-Based, Coach-Supervised, and Peer-Supported Lifestyle Program in Reducing Gastrointestinal and Extraintestinal Symptoms in Irritable Bowel Syndrome.
    Gastro Hep Adv. 2026;5:101087.
    PubMed    
    Abstract available
    
    

20. SILVA H, Knowles SR, Porter J, Barrett J, et al
    Disordered Eating Behaviors Many Years After Education in a Low FODMAP Diet in Patients With Irritable Bowel Syndrome.
    JGH Open. 2026;10:e70467.
    PubMed    
    Abstract available
    
    

21. RAHOU I, Gehrmann T, Ahannach S, Allonsius CN, et al
    Citizen science reveals comorbidities in endometriosis with no shift in vaginal microbiome composition.
    NPJ Womens Health. 2026;4:28.
    PubMed    
    Abstract available
    
    

22. GAO H, Schneider CV, Seibel T, Zhang C, et al
    No robust cortical morphometry differences and limited morphometry-phenotype associations in a UK Biobank irritable bowel syndrome phenotype.
    Neuroimage. 2026 Sep 8:122207. doi: 10.1016/j.neuroimage.2026.122207.
    PubMed    
    Abstract available
    
    

23. PIHLAJAMAKI H, Aitokari L, Nissinen K, Lehtonen S, et al
    Other special diets in addition to gluten-free diet are common among youth with celiac disease, but are not associated with overall well-being or treatment success.
    Nutr Health. 2026 Sep 7:2601060261484265. doi: 10.1177/02601060261484265.
    PubMed    
    Abstract available
    
    

24. ABI NASSIF M, El-Chammas K, Graham K, Sahay RD, et al
    Insurance Authorizations in Pediatric Disorders of Gut-Brain Interaction Treated With Auricular Neuromodulation: A Tertiary Center Experience.
    Neuromodulation. 2026 Jul 20:S1094-7159(26)01309.
    PubMed    
    Abstract available
    
    

25. CHANG L, Staller K, Houghton LA, Yerneni N, et al
    Effect of Age and Age-Defined Menopausal Status on Linaclotide Efficacy and Safety in Adults With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation: Post Hoc Analyses of Phase 2b/3 Studies.
    Neurogastroenterol Motil. 2026;38:e70429.
    PubMed    
    Abstract available
    
    

26. NAKAYA K, Nakaya N, Kogure M, Hatanaka R, et al
    Mortality in Irritable Bowel Syndrome: The Tohoku Medical Megabank Project Community-based Cohort Study.
    J Neurogastroenterol Motil. 2026 Sep 4. doi: 10.5056/jnm25142.
    PubMed    
    Abstract available
    
    

27. BIANCO A, Russo F, Prospero L, Laselva G, et al
    Divergent intestinal barrier and neuroimmune responses to supervised exercise across fibromyalgia, irritable bowel syndrome, and their comorbidity phenotypes: a prospective interventional study.
    Front Physiol. 2026;17:1912788.
    PubMed    
    Abstract available
    
    

28. KAUTZ M, Larson DT, Hseih HC, Maves RC, et al
    Post-Infectious Sequelae Following a Shiga Toxin-Producing Escherichia coli Outbreak Among US Marine Corps Recruits.
    Open Forum Infect Dis. 2026;13:ofag569.
    PubMed    
    Abstract available
    
    

29. PRIEGO-PARRA BA, Felix-Tellez FA
    Editorial: Beyond gastrointestinal symptoms: psychosocial implications of disorders of gut-brain interaction.
    Front Med (Lausanne). 2026;13:1965333.
    PubMed    
    
    
    

30. LIN J, Weng Z, Zhang F, Zhou Y, et al
    [Experimental studies on acupuncture-moxibustion for irritable bowel syndrome in the past five years: a literature analysis].
    Zhongguo Zhen Jiu. 2026;46:1554-1561.
    PubMed    
    Abstract available
    
    

31. ANCONA S, Ronchetti AB, Pescio E, Nobili L, et al
    Disorders of Gut-Brain Interaction in Juvenile Fibromyalgia Syndrome: Prevalence, Clinical Characteristics, and Management in a Single-Centre Cohort Study.
    J Rheumatol. 2026 Sep 15:jrheum.2025-1375. doi: 10.3899/jrheum.2025-1375.
    PubMed    
    Abstract available
    
    

32. WANG Y, Zou K, Liu D, Guo Q, et al
    Reproducibility of Published Meta-Analyses on Acupuncture for Irritable Bowel Syndrome.
    J Evid Based Med. 2026 Sep 15:e70188. doi: 10.1111/jebm.70188.
    PubMed    
    Abstract available
    
    

33. LIU G, Li M, Liu J, Li YP, et al
    Engineering Small Extracellular Vesicles for Colon-Targeted Delivery: Microenvironment-Responsive Design, Therapeutic Mechanisms, and Clinical Translation.
    Int J Nanomedicine. 2026;21:635349.
    PubMed    
    Abstract available
    
    

34. GOYAL MK, Lee A, Shah D, Brehmer S, et al
    Managing IBS-Like Symptoms in Quiescent Inflammatory Bowel Disease: A Meta-Analysis of Randomized Trials.
    Clin Gastroenterol Hepatol. 2026 Sep 25:S1542-3565(26)00725.
    PubMed    
    Abstract available
    
    

35. LI W, Jin Y, Ye Z, Ren Y, et al
    Irritable bowel syndrome and suicide risk among adolescents: a prospective cohort study.
    Lancet Reg Health West Pac. 2026;74:101984.
    PubMed    
    Abstract available
    
    

36. CHENG Y, Shu Q, Wang Z, Wu J, et al
    Causal effects of gut microbiota on functional gastrointestinal disorders: a bidirectional Mendelian randomization study.
    Exp Biol Med (Maywood). 2026;251:11023.
    PubMed    
    Abstract available
    
    

37. KASPRZAK Z, Jaczynska M, Jarzabek J, Salaga M, et al
    5-HT(7) receptor as a potential therapeutic target in irritable bowel syndrome: Current insights and future perspectives.
    Drug Discov Today. 2026 Sep 24:104811. doi: 10.1016/j.drudis.2026.104811.
    PubMed    
    Abstract available
    
    

38. SHORABAEV E, Sadanov A, Baimakhanova B, Ratnikova I, et al
    Safety and Effectiveness of Probiotic Preparations: A Contemporary Review.
    Diseases. 2026;14:316.
    PubMed    
    Abstract available
    
    

39. YAN R, Devine A, Lo J, Marlow E, et al
    Dietary fibre blend improves gut health in patients with irritable bowel syndrome following a low FODMAP diet: a randomised, double-blind control trial.
    Eur J Nutr. 2026;65:263.
    PubMed    
    Abstract available
    
    

40. WU W, You E, Li A, Chen J, et al
    Clinical and mechanistic responses to a music-based intervention for pain in adults with irritable bowel syndrome: Protocol for a single-arm pilot study.
    medRxiv [Preprint]. 2026 Sep 17:2026.09.11.26362754.
    PubMed    
    Abstract available
    
    

41. APPUTHURAI P, Palsson OS, Bangdiwala SI, Sperber AD, et al
    CONFIRMATORY VALIDATION AND CLUSTER CLASSIFICATION OF THE IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE (IBS-SSS).
    Value Health. 2026 Sep 23:S1098-3015(26)05755-4. doi: 10.1016/j.jval.2026.
    PubMed    
    Abstract available
    
    

42. MOON H, Yoon DE, Lee IS, Chae Y, et al
    Spatial Organization of Acupoint Selection Across Pain Conditions.
    Pain Res Manag. 2026;2026:e2707225.
    PubMed    
    Abstract available
    
    

43. ENGLISH CJ
    Potential duplicate inclusion of the same starch- and sucrose-reduced diet trial in a meta-analysis of dietary interventions for irritable bowel syndrome.
    Clin Nutr. 2026;66:106788.
    PubMed    
    
    
    

44. ZHANG SD, He JY, Zhang BR, Li KP, et al
    Liangfu Pill Alleviates Constipation-Predominant Irritable Bowel Syndrome through Modulation of 5-HT Signaling Pathway and Gut Microbiota.
    Chin J Integr Med. 2026 Sep 22. doi: 10.1007/s11655-026-3867.
    PubMed    
    Abstract available
    
    

45. LOVAS I, Landmark T, Rustoen T, Vedul-Kjelsas E, et al
    Distribution of chronic primary and secondary pain in a patient sample with psychiatric disorders.
    Scand J Pain. 2026;26.
    PubMed    
    Abstract available
    
    

46. KIM S, Loesch J, Short EJ, Singh P, et al
    The Associations Between Attention-Deficit/Hyperactivity Disorder Stimulant Medications and Irritable Bowel Syndrome.
    Clin Transl Gastroenterol. 2026 Sep 21. doi: 10.14309/ctg.0000000000001102.
    PubMed    
    Abstract available
    
    

47. YU C, Wang X, Chen S
    The Microbiota-Gut-Brain Axis in Disorders of Gut-Brain Interaction: Mechanisms and Emerging Therapeutic Strategies.
    Turk J Gastroenterol. 2026 Sep 15. doi: 10.5152/tjg.2026.25517.
    PubMed    
    Abstract available
    
    

48. HE J, Chen J, Zhang Y, Rao Y, et al
    Development and validation of a machine learning scoring system based on multi-dimensional metabolic signatures for invasive examination triage in intestinal diseases.
    Front Genet. 2026;17:1905165.
    PubMed    
    Abstract available
    
    

49. IBRAHIM F
    Rapidly Fermentable Prebiotic Substrates: Benefits, FODMAP Effects and Host Tolerance.
    Clin Nutr ESPEN. 2026 Sep 19:105130. doi: 10.1016/j.clnesp.2026.105130.
    PubMed    
    Abstract available
    
    

50. DELLSCHAFT N, Alhasani A, Reid JESJ, Hoad CL, et al
    Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.
    Aliment Pharmacol Ther. 2026 Sep 11. doi: 10.1111/apt.70964.
    PubMed    
    Abstract available
    
    

51. WILLIAMSON MLC PHD, Frutiger K PhD, Terry DL PhD
    Cognitive Behavior Therapy.
    Am Fam Physician. 2026;114:272-280.
    PubMed    
    Abstract available
    
    

52. WU J, Thongchuenjit S, Luo X, Yuan H, et al
    Comparison of demographic, clinical, and psychological characteristics among patients with irritable bowel syndrome meeting the Rome clinical, Rome V, and Rome IV criteria.
    Am J Gastroenterol. 2026 Sep 18. doi: 10.14309/ajg.0000000000004207.
    PubMed    
    Abstract available
    
    

53. VECSEI A, Hammer HF, Hammer J
    Lactose sensitivity and malabsorption in functional dyspepsia and functional dyspepsia-irritable bowel syndrome overlap.
    Digestion. 2026 Sep 7:1. doi: 10.1159.
    PubMed    
    Abstract available
    
    

54. PUOTI MG, Oorthuys AOJ, Vermeijden NK, Benninga MA, et al
    Pharmacotherapy of Irritable Bowel Syndrome with Constipation in Children: An Update on Clinical Progress and Successes.
    Drugs. 2026 Sep 23. doi: 10.1007/s40265-026-02376.
    PubMed    
    Abstract available
    
    

55. BALSIGER LM, Schol J, Raymenants K, Van de Bruaene C, et al
    Individualized targeted exclusion diet based on confocal laser endomicroscopy does not improve irritable bowel syndrome symptoms: a randomized controlled crossover trial.
    Gastroenterology. 2026 Sep 1:S0016-5085(26)07228.
    PubMed    
    Abstract available
    
    

56. WANG A, Sun Y
    Beyond average efficacy: how should patients be matched to gut-directed hypnotherapy for IBS?
    Gut. 2026 Sep 7:gutjnl-2026-340327. doi: 10.1136/gutjnl-2026-340327.
    PubMed    
    
    
    

57. BLACK CJ, Chuah KH
    Global epidemiology of disorders of gut-brain interaction: new insights with Rome V.
    Gut. 2026 Sep 15:gutjnl-2026-340229. doi: 10.1136/gutjnl-2026-340229.
    PubMed    
    
    
    

58. GOYAL MK, Goyal O, Sehgal T, Vuthaluru AR, et al
    What is new in Rome V?: Redefining diagnostic criteria and clinical pathways in disorders of gut-brain interaction.
    Indian J Gastroenterol. 2026 Sep 17. doi: 10.1007/s12664-026-02044.
    PubMed    
    Abstract available
    
    

59. MAHDI GA, Abotaiban N, Gadelmawla AF, Alfartaj M, et al
    Melatonin Supplementation in the Management of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2026 Sep 22. doi: 10.1111/jgh.70743.
    PubMed    
    Abstract available
    
    

60. KIM NM, Kim GJ
    Leveraging electronic health records for subtype-dependent directionality in depression and gastrointestinal disease: a retrospective cohort study.
    J Psychosom Res. 2026;211:112994.
    PubMed    
    Abstract available
    
    

61. JOHNSEN PH, Juul FE, Hoff DAL, Hillestad ER, et al
    Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2026 Sep 24:S0140-6736(26)01424-8. doi: 10.1016/S0140-6736(26)01424.
    PubMed    
    Abstract available
    
    

62. LIU J, Shin A
    Healthy donor faecal microbiota transplantation in irritable bowel syndrome: interpreting negative findings.
    Lancet. 2026 Sep 24:S0140-6736(26)01815-5. doi: 10.1016/S0140-6736(26)01815.
    PubMed